Exponent, Inc. (EXPO) 2015年年度报告「NASDAQ」.pdf

1、 2015 Annual Report Dear Fellow Stockholders:In 2015,we grew revenues,expanded margins and closed the year with strong earnings and a healthy balance sheet.For the year,total revenues increased 3%to$312.8 million and revenues before reimbursements reached$295.7 million.Net income increased 7%to$43.6

2、 million,or$1.60 per diluted share,and EBITDA rose to$76.4 million.We generated$60.5 million in cash from operating activities,and ended the year with$171.6 million in cash and short-term investments.We also repurchased$23.3 million in common stock and paid$15.6 million in dividends during the year.

3、While the decline in defense technology development and the completion of a major project in the third quarter created headwinds for top-line growth in 2015,we believe our bottom-line results and capital structure demonstrate the resilience of our model.In 2015,we experienced strong demand for our r

4、eactive and proactive services.We continue to assist clients with navigating the regulatory process and product performance assessments.We benefited from the broadening of product offerings and exploration of new materials in the consumer electronics and biomedical industries,as well as increased co

5、mmercial construction and infrastructure spending.As we move through 2016,we are focused on further expanding our unique market position in assessing reliability,safety,human health effects and environmental impacts of increasingly complex technologies,products,and processes.We will leverage our exp

6、erience and reputation in reactive services to continue the development of our proactive services,such as design evaluations,risk management and regulatory consulting.In summary,our long-term financial goals include producing organic revenue growth,improving profitability and maintaining a healthy b